Tag: KDC-MN-288

  • Liothyronine (T3)

    Active thyroid hormone (T3)

    The active thyroid hormone triiodothyronine; faster-acting and more potent than levothyroxine, used in hypothyroidism, depression augmentation, and metabolic research.

    Abstract

    Liothyronine (3,3′,5-triiodo-L-thyronine, T3; CAS 6893-02-3; molecular formula C15H12I3NO4; molecular weight 650.97) is the active thyroid hormone, marketed as Cytomel for hypothyroidism. The compound binds thyroid hormone receptors (TR-alpha, TR-beta) with approximately 4-fold higher affinity than thyroxine (T4) and produces direct genomic effects on metabolic gene transcription without the conversion delay required for T4. Plasma half-life is 2.5 days, much shorter than T4’s 7-day half-life, producing more variable plasma levels but faster onset and offset. Approved for hypothyroidism (alternative or adjunct to levothyroxine), myxedema coma (intravenous), and as a thyroid suppression test. The cardiac risk is the principal limitation: T3 directly increases myocardial oxygen demand, producing tachycardia, atrial fibrillation, and angina at supratherapeutic doses. Used as the canonical T3 reference compound.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.